MYP_065751
NN2211 (Glucagon- Like Peptide 1 Derivative)
Metabolic
▸
Glucose metabolism
▸
Metabolic
▸
Glucose metabolism
▸
Antidiabetic
▸
Standard
31 amino acids
C151H228N42O47
Standard
HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG
3383.68 Da
5.53
-1.15
-1.41
-0.0369
-0.25
0.57
0.06
15.64
69.35
0.1290
6990.00
6990.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
1444.28
-15.15
52.0
47.0
110.0
240.0
6.0
31.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0272352
VERIFIED: YES
Provenance & Taxonomy
not reported [other]
GLP-1
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
γ-Glu-palmitoyl residue at position 21
Bio-Activity Profile
Anti-diabetic
Subcutaneously injected in Humans, in vivo; 39600 s
RECORD: Rec_0343028
VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GLP-1
9606;32630
Structure & Mods
branched peptide architecture [Branched]
canonical L-amino-acid peptide [L]
Side-chain acyl/linker conjugation
Bio-Activity Profile
Antidiabetic
GLP-1 receptor agonist
Weight management
Human GLP-1 receptor
Clinical/Human: 13 h